![](https://investorshub.advfn.com/uicon/198810.png?cb=1585642903)
Thursday, January 16, 2020 8:41:00 AM
# $32,943,322 total sales/billing numbers from the past 3 months (04/16/19 to 08/02/19) for Arrayit (@Arrayit on Twitter)
# received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii
# Arrayit recently completed an allergy testing pilot program for a top retail chain,
# established a nationwide network of 1,700 allergy sales professionals,
# met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line,
# fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer,
# announced allergy testing partnerships with major allergy therapeutics providers,
# received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations,
# announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company’s Chief Executive Officer,
# received endorsement by First Pediatrics Medical Group,
# announced in-network allergy testing services contracting with a top five commercial health benefits company,
# doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth,
# expanded allergy testing services evaluation with a major retail pharmacy chain,
# grew its allergy testing healthcare network to more than 700 clinics,
# retained a top credentialing company to accelerate commercial and government payor reimbursement,
# aced five consecutive rounds of proficiency testing with a top proficiency testing leader and signed an in-network allergy testing services agreement with a major California-based health benefits company.
Healthcare testing services covered by Medicare Part B will be reported as revenues and earnings in the company’s upcoming audited financial statements
CDPH licensure extension into 2020 is expected to substantially facilitate quarterly and fiscal year 2019 and 2020 revenues and earnings, which will be reported in the company’s upcoming audited financial statements
CDPH ensures public health for individuals, families and communities by confirming proper clinical laboratory operation from its healthcare providers in the nation’s most populous state, comprising 39 million residents and an annual healthcare expenditure topping 294,000,000,000 ($294 billion).
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM